Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK

Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK

US Patent 8101799 · Granted Jan 24, 2012

Estimated economic value: $4,673,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pharmaceutical composition containing brexanolone, ganaxolone, or zuranolone, an2025
Conjugates comprising cleavable beta-glucuronide-containing linkers2025
Combination therapy for HIV with adenosine derivative and capsid inhibitors2025
Anti-ROR1 antibody conjugates, compositions comprising anti ROR1 antibody conjug2025
Conjugates comprising cleavable linkers2024
Tricyclic pyridones and pyrimidones2024
Anti-ROR1 antibody conjugates, compositions comprising anti ROR1 antibody conjug2024
Tricyclic compounds, compositions and medicinal applications thereof2024
Combination therapy for HIV with adenosine derivative and capsid inhibitors2024
Tricyclic pyridones and pyrimidones2023
Immunomodulator antibody drug conjugates and uses thereof2023
Tricyclic compounds, compositions and medicinal applications thereof2022